United States· US:72241-036_eb7928f4-e0c7-4f23-a1a8-934d82f5eca4
Erythromycin
A erythromycin product containing erythromycin, registered in United States by Modavar Pharmaceuticals LLC. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Erythromycin is registered in 13 of 19 countries.
Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Erythromycin · ATC J01FA01
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ERYTHROMYCIN
- Manufacturer
- Modavar Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- J01FA01
- ATC class
- Erythromycin
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1172241-036-05
- ndc1172241-036-22
- ndc117224103605100 TABLET, FILM COATED in 1 BOTTLE (72241-036-05)
- ndc11722410362230 TABLET, FILM COATED in 1 BOTTLE (72241-036-22)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1011 interactions on record for erythromycin.
Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Erythromycin · interactions on record
1011 records
- 216 severe
- 424 moderate
- 70 minor
- 227 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
74 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Erythromycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayErythrocinAmdipharm UK Limited
- FinlandAbboticinAbbott Scandinavia AB
- IrelandErythrocin 250 mg tabletsAmdipharm Limited
- SwedenAbboticin 250 mg Filmdragerad tablettAmdipharm Limited
- United KingdomEryacne 2 gelGalderma (UK) Ltd
- PolandAknemycinLaboratorium Galenowe Olsztyn Sp. z o.o.
- SpainDERIPIL GELLaboratorio Reig Jofre, S.A.
- FranceERY 500 mg, compriméBOUCHARA-RECORDATI
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Belgium · Erycine, Erythrocine
- Cyprus · Ermyced, Ermycin
- Czechia · Aknemycin
- Germany · Aknemycin, Erythromycin Panpharma
- Denmark · Abboticin, Erythromycin Panpharma
- Spain · Eritromicina Panpharma, Oftalmolosa Cusí Eritromicina
- Finland · Abboticin, Abboticin Novum
- France · Ery, Ery Nourrissons
- United Kingdom (Northern Ireland) · Erythrocin 250, Erythrocin 500
- Greece · Acne Hermal, Dankit
- Croatia · Eritromicin Belupo
- Hungary · Aknemycin
- Ireland · Erythrocin
- Italy · Eritromicina Idi
- Lithuania · Erythromycin Tc
- Luxembourg · Aknemycin, Ery
- Latvia · Erythromycin Tzf
- Netherlands · Erythrocine, Erythrocine Es
- Norway · Abboticin, Ery-Max
- Poland · Aknemycin, Cusi
- Portugal · Akne-Mycin, Clinac
- Romania · Eritromicină Atb
- Sweden · Abboticin, Abboticin Novum
- Slovakia · Aknemycin, Aknemycin 2000
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe2c125c-5fa4-4f9d-8e77-f5970a39b7bd GET /v1/drugs/fe2c125c-5fa4-4f9d-8e77-f5970a39b7bd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "ERYTHROMYCIN",
"productndc": "72241-036",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213628",
"marketing_category": "ANDA"
}See everything about erythromycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.